Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)
Summary
In this episode, Jessica Johnson and Whitney Theiss from Neurocrine Biosciences join Tom Caravela to explore the transition from clinical roles to field medical positions, focusing on the Clinical Practice Liaison (CPL) role. They discuss the responsibilities and skills required for CPLs, comparing them to those of Medical Science Liaisons (MSLs). The episode delves into the challenges CPLs face, performance evaluation, and career progression, including the impact of remote work trends. Jessica and Whitney offer valuable advice for clinicians considering a transition, emphasizing the significance of emotional intelligence. The episode wraps up with key takeaways and closing thoughts.
My guests today are Jessica Johnson Director, Clinical Practice Liaisons and Whitney Tice, Clinical Practice Liaison at Neurocrine and we discuss the path from clinical practice to Field Medical.
In this episode we discuss:
- Jessica and Whitney’s background
- The transition from clinician into industry
- Why are clinicians good candidates for Field Medical positions
- What is a clinical practice liaison, responsibilities and difference from an MSL
- What are the skill sets they look for in a CPL when hiring
- What types of training is required for CPLs and the implemented in the organization
- What makes a top-performing CPL
- What can people aspire from the CPL role
- Advice for a clinician trying to get into the role and how they can be successful
Clinical Practice Liaison, Field Medical Positions, Medical Science Liaisons, Transition to Industry, Emotional Intelligence in Healthcare
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO